Amyris announces receipt of $10 million milestone payment from LAVVAN
Amyris reported it has received from its cannabinoid partner, LAVVAN, a first cash payment of $10 million for having successfully delivered on its first major collaboration milestone. The company expects to bring the first fermentation-derived cannabinoid products to market next year. May 20, 2019